Knockdown of MicroRNA-155 in kupffer cells results in immunosuppressive effects and prolongs survival of mouse liver allografts

Transplantation

Volumn 97, Issue 6, 2014, Pages 626-635

  Li, Jinzheng ^a   Gong, Junhua ^a   Li, Peizhi ^a   Li, Min ^a   Liu, Yiming ^a   Liang, Shaoyong ^a   Gong, Jianping ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Acute rejection; Kupffer cells; Liver transplantation; MicroRNA 155

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; JANUS KINASE 2; LENTIVIRUS VECTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MICRORNA 155; SHORT HAIRPIN RNA; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURFACE; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; GRAFT SURVIVAL; KUPFFER CELL; LIVER GRAFT; LIVER TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MALE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 TH2 BALANCE;

ANIMALS; ANTIGENS, CD40; ANTIGENS, CD86; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; JANUS KINASES; KUPFFER CELLS; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICRORNAS; PHENOTYPE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TH1 CELLS; TH2 CELLS; TIME FACTORS; TRANSFECTION;

EID: 84897028623     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000061     Document Type: Article

References (42)

1. Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology 2006; 43: S54.
2. Knechtle SJ, Kwun J. Unique aspects of rejection and tolerance in liver transplantation. Semin Liver Dis 2009; 29: 91.
3. Crispe IN, Giannandrea M, Klein I, et al. Cellular and molecular mechanisms of liver tolerance. Immunol Rev 2006; 213: 101.
4. Thomson AW, Knolle PA. Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol 2010; 10: 753.
5. Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int 2006; 26: 1175.
6. Chen Y, Liu Z, Liang S, et al. Role of Kupffer cells in the induction of tolerance of orthotopic liver transplantation in rats. Liver Transpl 2008; 14: 823.
7. Chen Y, Chen J, Liu Z, et al. Relationship between TH1/TH2 cytokines and immune tolerance in liver transplantation in rats. Transplant Proc 2008; 40: 2691.
8. Chen Y, Liu H, Liu Z, et al. Blockade of inducible costimulator pathway to prevent acute rejection in rat liver transplantation. Am J Surg 2009; 198: 244.
9. Chen Y, Yan T, Shi LJ, et al. Knockdown of interleukin-2 by shRNAmediated RNA interference prolongs liver allograft survival. J Surg Res 2010; 159: 582.
10. Lian ZR, Xu YF, Wang XB, et al. Suppression of histone deacetylase 11 promotes expression of IL-10 in Kupffer cells and induces tolerance following orthotopic liver transplantation in rats. J Surg Res 2012; 174: 359.
11. Li J, Lai X, Liao W, et al. The dynamic changes of Th17/Treg cytokines in rat liver transplant rejection and tolerance. Int Immunopharmacol 2011; 11: 962.
12. Thai TH, Calado DP, Casola S, et al. Regulation of the germinal center response by microRNA-155. Science 2007; 316: 604.
13. Rodriguez A, Vigorito E, Clare S, et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007; 316: 608.
14. O'Connell RM, Taganov KD, Boldin MP, et al. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 2007; 104: 1604.
15. O'Connell RM, Rao DS, Chaudhuri AA, et al. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010; 10: 111.
16. Teng G, Papavasiliou FN. Shhh! Silencing by microRNA-155. Philos Trans R Soc Lond B Biol Sci 2009; 364: 631.
17. Ceppi M, Pereira PM, Dunand-Sauthier I, et al. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci U S A 2009; 106: 2735.
18. Martinez-Nunez RT, Louafi F, Friedmann PS, et al. MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN). J Biol Chem 2009; 284: 16334.
19. Mas VR, Dumur CI, Scian MJ, et al. MicroRNAs as biomarkers in solid organ transplantation. Am J Transplant 2013; 13: 11.
20. Spiegel JC, Lorenzen JM, Thum T. Role of microRNAs in immunity and organ transplantation. Expert Rev Mol Med 2011; 13: E37.
21. Anglicheau D, Muthukumar T, Suthanthiran M. MicroRNAs: Small RNAs with big effects. Transplantation 2010; 90: 105.
22. Jiang S, Zhang HW, Lu MH, et al. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 2010; 70: 3119.
23. Wang P, Hou J, Lin L, et al. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J Immunol 2010; 185: 6226.
24. Lu LF, Thai TH, Calado DP, et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 2009; 30: 80.
25. Alexander WS. Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2002; 2: 410.
26. Fu H, Song S, Liu F, et al. Dendritic cells transduced with SOCS1 gene exhibit regulatory DC properties and prolong allograft survival. Cell Mol Immunol 2009; 6: 87.
27. Hanada T, Tanaka K, Matsumura Y, et al. Induction of hyper Th1 cell-Type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene. J Immunol 2005; 174: 4325.
28. Croker BA, Kiu H, Nicholson SE. SOCS regulation of the JAK/STAT signalling pathway. Semin Cell Dev Biol 2008; 19: 414.
29. Tamiya T, Kashiwagi I, Takahashi R, et al. Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: Regulation of T-cell inflammation by SOCS1 and SOCS3. Arterioscler Thromb Vasc Biol 2011; 31: 980.
30. Sa'nchez-Fueyo A, Strom TB. Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs. Gastroenterology 2011; 140: 51.
31. Neil DA, Hübscher SG. Current views on rejection pathology in liver transplantation. Transpl Int 2010; 23: 971.
32. Ferguson TA, Griffith TS. A vision of cell death: Fas ligand and immune privilege 10 years later. Immunol Rev 2006; 213: 228.
33. Villa-Morales M, Ferna'ndez-Piqueras J. Targeting the Fas/FasL signaling pathway in cancer therapy. Expert Opin Ther Targets 2012; 16: 85.
34. Miyagawa-Hayashino A, Tsuruyama T, Egawa H, et al. FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts. Am J Pathol 2007; 171: 1499.
35. Peng Y, Gallagher SF, Haines K, et al. Nuclear factor-kappaB mediates Kupffer cell apoptosis through transcriptional activation of Fas/FasL. J Surg Res 2006; 130: 58.
36. Ma X, Becker Buscaglia LE, Barker JR, et al. MicroRNAs in NF-kappaB signaling. J Mol Cell Biol 2011; 3: 159.
37. Montagner S, Orlandi EM, Merante S, et al. The role of miRNAs in mast cells and other innate immune cells. Immunol Rev 2013; 253: 12.
38. Vigorito E, Kohlhaas S, Lu D, et al. miR-155: An ancient regulator of the immune system. Immunol Rev 2013; 253: 146.
39. Kamada N, Calne RY. A surgical experience with five hundred thirty liver transplants in the rat. Surgery 1983; 93: 64.
40. Qian S, Fung JJ, Demetris AJ, et al. Allogeneic orthotopic liver transplantation in mice: A preliminary study of rejection across welldefined MHC barriers. Transplant Proc 1991; 23: 705.
41. Demetris AJ, Batts KP, Dhillon AP, et al. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997; 25: 658.
42. Höroldt BS, Burattin M, Gunson BK, et al. Does the Banff rejection activity index predict outcome in patients with early acute cellular rejection following liver transplantatioñ Liver Transpl 2006; 12: 1144.